Gracell Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRCL and buy or sell other stocks, ETFs, and their options commission-free!About GRCL
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives.
CEOWei Cao, PhD
CEOWei Cao, PhD
Employees—
Employees—
HeadquartersSuzhou, Shanghai
HeadquartersSuzhou, Shanghai
Founded2017
Founded2017
Employees—
Employees—
GRCL Key Statistics
Market cap983.25M
Market cap983.25M
Price-Earnings ratio-10.08
Price-Earnings ratio-10.08
Dividend yield—
Dividend yield—
Average volume930.52K
Average volume930.52K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.44
52 Week high$10.44
52 Week low$1.40
52 Week low$1.40